Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1984;4:138-146

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tikkanen, M. J.
Right arrow Articles by Schonfeld, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tikkanen, M. J.
Right arrow Articles by Schonfeld, G.

Arteriosclerosis, Vol 4, 138-146, Copyright © 1984 by American Heart Association


ARTICLES

Expression of apolipoprotein B epitopes in very low density lipoprotein subfractions. Studies with monoclonal antibodies

MJ Tikkanen, TG Cole, KS Hahm, ES Krul and G Schonfeld

Epitope expression was studied in both denatured apolipoprotein B (apo B) on Western blots and in intact low density lipoprotein (LDL) and very low density lipoprotein subfractions VLDL1 (Sf120-400), VLDL2 (Sf60-120), and VLDL3 (Sf20-60) in competitive binding immunoassays with the aid of six monoclonal anti-LDL antibodies. The apo B in all lipoprotein fractions was shown to bind to all antibodies, but significant differences in apo B epitope expression were observed. On the average, the immunoreactivity of VLDL subfractions (expressed as binding affinity and as relative 125I-LDL displacing potency) decreased with increasing flotation rate. Similarly, VLDL1 was less immunoreactive than lipolyzed "remnants" of VLDL1 after treatment with bovine milk lipoprotein lipase. The results indicate that, even when lipoprotein fractions obtained from the same individual and having the same kind of apo B subspecies were compared, significant differences in immunoreactivity occurred due to the modulating effect of other lipoprotein components on apo B epitope expression.


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Wang, R. Pease, J. Bertinato, and R. W. Milne
Well-Defined Regions of Apolipoprotein B-100 Undergo Conformational Change During Its Intravascular Metabolism
Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1301 - 1308.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
E. D. Breyer, N.-A. Le, X. Li, D. Martinson, and W. V. Brown
Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size
J. Lipid Res., October 1, 1999; 40(10): 1875 - 1882.
[Abstract] [Full Text]